GlassScriptPhysician profile
Lisa M Traina
NPI 1538830799
$3,267.78
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,713 · 2023: $1,033 · 2024: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,554.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $680.93 | 2022-2024 | Farxiga, Airsupra, Lokelma |
| Glaxosmithkline, LLC. | $674.69 | 2022-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $655.61 | 2022-2024 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $230.32 | 2022-2024 | |
| Lilly USA, LLC | $212.72 | 2022-2024 | Zepbound, Mounjaro |
| Exact Sciences Corporation | $189.62 | 2023-2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $166.41 | 2022 | |
| Esperion Therapeutics, INC. | $95.06 | 2022 | |
| Sunovion Pharmaceuticals INC. | $76.73 | 2022 | |
| Grifols USA, LLC | $71.96 | 2022-2023 | Prolastin-C Liquid |
| Amgen INC. | $35.72 | 2024 | Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.40 | 2022 | |
| Almatica Pharma LLC | $23.58 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.52 | 2022 | |
| Daiichi Sankyo INC. | $19.87 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $19.85 | 2022 | |
| Novartis Pharmaceuticals Corporation | $18.11 | 2024 | |
| Pfizer INC. | $16.19 | 2023 | |
| Janssen Pharmaceuticals, INC | $15.17 | 2022 | |
| Sanofi-Aventis U.S. LLC | $13.32 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Traina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.